184 related articles for article (PubMed ID: 34299636)
1. The HDAC/HSP90 Inhibitor G570 Attenuated Blue Light-Induced Cell Migration in RPE Cells and Neovascularization in Mice through Decreased VEGF Production.
Hsu TJ; Nepali K; Tsai CH; Imtiyaz Z; Lin FL; Hsiao G; Lai MJ; Cheng YW
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299636
[TBL] [Abstract][Full Text] [Related]
2. Establishing Liposome-Immobilized Dexamethasone-Releasing PDMS Membrane for the Cultivation of Retinal Pigment Epithelial Cells and Suppression of Neovascularization.
Lin TW; Chien Y; Lin YY; Wang ML; Yarmishyn AA; Yang YP; Hwang DK; Peng CH; Hsu CC; Chen SJ; Chien KH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634448
[TBL] [Abstract][Full Text] [Related]
3. Dual Targeting Strategies on Histone Deacetylase 6 (HDAC6) and Heat Shock Protein 90 (Hsp90).
Bonanni D; Citarella A; Moi D; Pinzi L; Bergamini E; Rastelli G
Curr Med Chem; 2022; 29(9):1474-1502. PubMed ID: 34477503
[TBL] [Abstract][Full Text] [Related]
4. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
Tao H; Chen YY; Sun ZW; Chen HL; Chen M
J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
[TBL] [Abstract][Full Text] [Related]
5. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
6. Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment.
Wu TY; Chen M; Chen IC; Chen YJ; Chen CY; Wang CH; Cheng JJ; Nepali K; Chuang KH; Liou JP
J Adv Res; 2023 Apr; 46():159-171. PubMed ID: 35752438
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344.
Dawood M; Fleischer E; Klinger A; Bringmann G; Shan L; Efferth T
Pharmacol Res; 2020 Oct; 160():105076. PubMed ID: 32659428
[TBL] [Abstract][Full Text] [Related]
8. Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo.
Ojha R; Nepali K; Chen CH; Chuang KH; Wu TY; Lin TE; Hsu KC; Chao MW; Lai MJ; Lin MH; Huang HL; Chang CD; Pan SL; Chen MC; Liou JP
Eur J Med Chem; 2020 Mar; 190():112086. PubMed ID: 32058238
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational modification and beyond: interplay between histone deacetylase 6 and heat-shock protein 90.
Liu P; Xiao J; Wang Y; Song X; Huang L; Ren Z; Kitazato K; Wang Y
Mol Med; 2021 Sep; 27(1):110. PubMed ID: 34530730
[TBL] [Abstract][Full Text] [Related]
10. 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC.
Ojha R; Huang HL; HuangFu WC; Wu YW; Nepali K; Lai MJ; Su CJ; Sung TY; Chen YL; Pan SL; Liou JP
Eur J Med Chem; 2018 Apr; 150():667-677. PubMed ID: 29567459
[TBL] [Abstract][Full Text] [Related]
11. HSP90 acts as a senomorphic target in senescent retinal pigmental epithelial cells.
Chen DD; Peng X; Wang Y; Jiang M; Xue M; Shang G; Liu X; Jia X; Liu B; Lu Y; Mu H; Zhang F; Hu Y
Aging (Albany NY); 2021 Sep; 13(17):21547-21570. PubMed ID: 34495872
[TBL] [Abstract][Full Text] [Related]
12. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion.
Zhu K; Zhang Y; Zhang J; Zhou F; Zhang L; Wang S; Zhu Q; Liu Q; Wang X; Zhou L
Toxicol Lett; 2020 Mar; 320():19-27. PubMed ID: 31778773
[TBL] [Abstract][Full Text] [Related]
13. TAS-116, a Well-Tolerated Hsp90 Inhibitor, Prevents the Activation of the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells.
Ranta-Aho S; Piippo N; Korhonen E; Kaarniranta K; Hytti M; Kauppinen A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062977
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.
Joshi AD; Barabutis N; Birmpas C; Dimitropoulou C; Thangjam G; Cherian-Shaw M; Dennison J; Catravas JD
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1410-9. PubMed ID: 26498249
[TBL] [Abstract][Full Text] [Related]
15. Targeting HSP90-HDAC6 Regulating Network Implicates Precision Treatment of Breast Cancer.
Yu S; Cai X; Wu C; Liu Y; Zhang J; Gong X; Wang X; Wu X; Zhu T; Mo L; Gu J; Yu Z; Chen J; Thiery JP; Chai R; Chen L
Int J Biol Sci; 2017; 13(4):505-517. PubMed ID: 28529458
[TBL] [Abstract][Full Text] [Related]
16. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APE1/Ref-1 redox activity rescues human retinal pigment epithelial cells from oxidative stress and reduces choroidal neovascularization.
Li Y; Liu X; Zhou T; Kelley MR; Edwards P; Gao H; Qiao X
Redox Biol; 2014; 2():485-94. PubMed ID: 24624338
[TBL] [Abstract][Full Text] [Related]
18. Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors.
Tavares MT; Kozikowski AP; Shen S
Eur J Med Chem; 2021 Jan; 209():112887. PubMed ID: 33035922
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors.
Jo DH; An H; Chang DJ; Baek YY; Cho CS; Jun HO; Park SJ; Kim JH; Lee HY; Kim KW; Lee J; Park HJ; Kim YM; Suh YG; Kim JH
J Mol Med (Berl); 2014 Oct; 92(10):1083-92. PubMed ID: 24875598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
